CHRISTOPHER METCALF: Open Payments
NPI 1437782174 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,128 in 61 payments from 9 companies in 2025. Trend: 2023 $122 · 2024 $507 · 2025 $1,128
Food & beverage: $1,128
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 11 | $231 |
| ABBVIE INC. | 17 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $215 |
| Indivior Inc. | 9 | $179 |
| Alkermes, Inc. | 4 | $102 |
| Otsuka America Pharmaceutical, Inc. | 3 | $93 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Orexo US, Inc. | 1 | $22 |
| Braeburn Inc. | 1 | $18 |
Products named: CAPLYTA, SUBLOCADE, MAVYRET, REXULTI, VRAYLAR, VIVITROL, Auvelity, LYBALVI.
Industry payments across KY — which companies pay providers there.
